The prevalence of irritable bowel syndrome‐type symptoms in paediatric inflammatory bowel disease, and the relationship with biochemical markers of disease activity

Authors:

Abstract
Summary: Background: A large proportion (25–46%) of adults with inflammatory bowel disease in remission has symptoms of irritable bowel syndrome (IBS), which are thought to reflect ongoing inflammation. Data on paediatric inflammatory bowel disease patients are lacking.Aim: To investigate (i) the prevalence of IBS‐type symptoms in paediatric inflammatory bowel disease patients in remission and (ii) the relationship of IBS‐type symptoms with biochemical markers of disease activity.Methods: This cross‐sectional study included all patients (P = 0.12; CRP: IBS+ median 1.4 mg/L, IBS− 1.1 mg/L, P = 0.63).Conclusions: The prevalence of IBS‐type symptoms in children with inflammatory bowel disease is highly dependent on the definition of remission. Nonetheless, the prevalence is much lower than that previously reported in studies in adult inflammatory bowel disease patients. IBS‐type symptoms appear to be unrelated to gastrointestinal inflammation.

This publication has 24 references indexed in Scilit: